KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Asset Writedowns and Impairment (2016 - 2019)

Historic Asset Writedowns and Impairment for Quest Diagnostics (DGX) over the last 11 years, with Q4 2019 value amounting to $2.0 million.

  • Quest Diagnostics' Asset Writedowns and Impairment fell 5000.0% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.0 million, marking a year-over-year increase of 8333.33%. This contributed to the annual value of $5.0 million for FY2024, which is 40000.0% up from last year.
  • According to the latest figures from Q4 2019, Quest Diagnostics' Asset Writedowns and Impairment is $2.0 million, which was down 5000.0% from $4.0 million recorded in Q3 2019.
  • In the past 5 years, Quest Diagnostics' Asset Writedowns and Impairment ranged from a high of $86.0 million in Q1 2016 and a low of -$235.0 million during Q4 2016
  • Its 5-year average for Asset Writedowns and Impairment is $16.4 million, with a median of $3.5 million in 2017.
  • In the last 5 years, Quest Diagnostics' Asset Writedowns and Impairment plummeted by 46153.85% in 2016 and then soared by 13333.33% in 2019.
  • Quarter analysis of 5 years shows Quest Diagnostics' Asset Writedowns and Impairment stood at $65.0 million in 2015, then plummeted by 461.54% to -$235.0 million in 2016, then skyrocketed by 101.28% to $3.0 million in 2017, then soared by 33.33% to $4.0 million in 2018, then crashed by 50.0% to $2.0 million in 2019.
  • Its Asset Writedowns and Impairment was $2.0 million in Q4 2019, compared to $4.0 million in Q3 2019 and $1.0 million in Q2 2019.